# A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

> **NCT06747351** · PHASE3 · RECRUITING · sponsor: **Takeda** · enrollment: 59 (estimated)

## Conditions studied

- Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

## Interventions

- **BIOLOGICAL:** TAK-881
- **BIOLOGICAL:** HYQVIA
- **DEVICE:** SC Investigational Needle Sets

## Key facts

- **NCT ID:** NCT06747351
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-06
- **Primary completion:** 2028-06-25
- **Final completion:** 2028-06-25
- **Target enrollment:** 59 (ESTIMATED)
- **Last updated:** 2026-01-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06747351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06747351, "A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06747351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*